Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

William L. Dahut, Nehal J. Lakhani, James L. Gulley, Philip M. Arlen, Elise C. Kohn, Herbert Kotz, Debbie McNally, Allyson Pair, Diana Nguyen, Sherry X. Yang, Seth M. Steinberg, Jürgen Venitz, Alex Sparreboom, William D. Figg^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review